ACHV
Achieve Life Sciences Inc
7.50$
-3.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Achieve Life Sciences Inc (ACHV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.5 | 1.4 | -10 | -0.1 | -4.0 | 1.2 | -10 | -9.9 | -15 | -8.4 | -20 | -23 | -12 | 35 | -27 | -20 | -43 | -36 | -17 | -9.1 | -30 | -9.1 | -11 | -15 | -13 | -29 | -38 | -24 | -30 | -49 | |
| 0.5 | 0.6 | 0.8 | 0.6 | 0.4 | 0.3 | 0.6 | 0.4 | 0.5 | 0.6 | 0.6 | 0.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | |
| – | – | – | – | – | 50 | – | – | – | – | 2,173 | 1,661 | 0.2 | 0.4 | 0.6 | 1.2 | 2.2 | 2.8 | 3.9 | 2.3 | 1.6 | 0.3 | 0.9 | 1.2 | 1.3 | 2.2 | 3.3 | 3.4 | 5.3 | 8.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6.2 | -3.9 | -0.4 | -2.9 | 0.4 | 1.0 | 4.5 | 0.9 | 1.2 | 1.3 | 2.2 | 3.3 | – | – | – | |
| 1.1 | -0.3 | -9.6 | -1.1 | -2.2 | 0.4 | 0.7 | 0.2 | 1.2 | 12 | 1.4 | -12 | -4.3 | 40 | -20 | 0.5 | -18 | -3.9 | 12 | 7.0 | -11 | -3.1 | 0.9 | -0.3 | -0.3 | 1.2 | 0.1 | -0.8 | 2.4 | -4.3 | |
| 0.5 | 1.2 | 0.5 | 0.1 | 0.0 | 0.2 | 0.9 | 0.7 | 0.4 | 0.1 | 0.8 | 1.4 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.3 | 0.1 | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -5.9 | -4.6 | 9.1 | 0.8 | 4.2 | -8.0 | -2.4 | -2.7 | -2.6 | 20 | -23 | -6.1 | 15 | 2.2 | -59 | 25 | -21 | 32 | 5.4 | -2.1 | 11 | 13 | -5.1 | 5.0 | 0.0 | 0.0 | – | 0.0 | -22 | 6.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 4.2 | 0.6 | 0.2 | 0.1 | 0.6 | 5.2 | 13 | 14 | 16 | 37 | – | – | 0.0 | 0.1 | 47 | 0.2 | 54 | 0.0 | 22 | 0.0 | 0.0 | 0.0 | 15 | 5.0 | 33 | – | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.9 | 3.6 | 0.2 | 1.9 | 15 | 15 | 15 | 15 | 0.0 | 0.0 | -8.3 | 5.0 | |
| 4.0 | 1.2 | 1.2 | 0.1 | 0.6 | 5.5 | 13 | 14 | 16 | 37 | 29 | 0.2 | 0.1 | 17 | 47 | 0.2 | 54 | 0.0 | 25 | 18 | 0.0 | 2.0 | 20 | 17 | 33 | 37 | 19 | 15 | 49 | 52 | |
| 1.6 | -2.0 | 1.2 | 0.7 | 0.8 | -1.2 | -0.1 | 1.3 | -1.3 | 49 | -14 | -29 | 3.0 | 54 | -39 | 5.0 | -10 | -3.5 | 13 | 6.4 | -19 | 5.5 | 4.0 | 7.1 | 19 | 7.2 | -18 | -9.2 | -2.8 | 8.2 | |
| 3.0 | 0.2 | -11 | -0.1 | -4.0 | 1.1 | -11 | -11 | -15 | -8.5 | -20 | -25 | -12 | 35 | -27 | -20 | -44 | -36 | -17 | -9.5 | -30 | -9.1 | -11 | -15 | -13 | -29 | -38 | -25 | -30 | -49 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.